BIOMENDICS

BioMendics was founded by scientists, physicians, and angel investors with a shared vision and desire to bring decades of research into small molecule liquid crystal technology out of the laboratory and into the clinic to help the people that need it most... BioMendics is committed to advancing its small molecule liquid crystal MTORX™ Technology to develop life-enhancing medicines for people suffering from epidermolysis bullosa, epidermolytic ichthyosis, pachyonychia congenita, and other rare dermatologic disorders... BioMendics is developing liquid crystal medication for patients with rare dermatologic disorders. Their lead clinical program is focused on epidermolysis bullosa simplex. Learn more.

Also known as: BioMendics, LLC

Primary location: Rootstown United States